Abstract
The word cachexia is derived from the Greek words kakòs, meaning ‘bad,’ and hexis, meaning ‘condition’ [1]. From an epidemiological point of view, while patients with haematological malignancies and breast cancer seldom have this syndrome, most other solid tumours are associated with a high frequency of cachexia [2]. Indeed, its prevalence increases from 50% to more than 80% before death, and in more than 20% of patients cachexia is the main cause of death [3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tisdale MJ (1997) Biology of cachexia. J Natl Cancer Inst 89:1763–1773
Inui A (2002) Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 52:72–91
Bruera E (1997) Anorexia, cachexia and nutrition. BMJ 315:1219–1222
Yancik R (1997) Cancer burden in the aged: an epidemiological and demographic overview. Cancer 80:1273–1283
Wildiers H, Highley MS, dei Bruijn EA et al (2003) Pharmacology of anticancer drugs in the elderly population. Clin Pharmacokinet 42:1–30
Tisdale MJ (2000) Metabolic abnormalities in cachexia and anorexia. Nutrition 16:1013–1014
Kotler DP (2000) Cachexia. Ann Intern Med 133:622–634
Vestal RE (1997) Aging and pharmacology. Cancer 80:1302–1310
Skirvin JA, Lichtman SM (2002) Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer. Drugs Aging 19:25–42
Raghuram TC, Krishnasvamy K (1981) Tetracycline absorption in malnutrition. Drug Nutr Interact 1:23–29
Lichtman SM, Skirvin JA (2000) Pharmacology of antineoplastic agents in older cancer patients. Oncology 14:1743–1763
Mangoni AA, Jackson SH (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57:6–14
Schrijvers D, Highley M, De Bruyn E et al (1999) Role of red blood cells in pharmacokinetics of chemotherapeutic agents. Anticancer Drugs 10:147–153
Sotaniemi EA, Arranto AJ, Pelkonen O et al (1997) Age and cytochrome P450-Iinked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharm Ther 61:331–339
Corcoran MB (1998) Polypharmacy in the older patient. In: Balducci L, Lyman GH, Ershler WB Comprehensive geriatric oncology. Harwood Academic Publishers, London, pp 525–532
John V, Mashru S, Lichtman J (2003) Pharmacological factors influencing anticancer drug selection in the el-derly. Drugs Aging 20:737–759
Jorquera F, Culebras DM, Gonzalezgallego J (1996) Influence of nutrition on liver oxidative metabolism. Nutrition 12:442–447
Sadean MR, Glass PS (2003) Pharmacokinetics in the elderly. Best Pract Res Clin Anaesthesiol 17:191–205
Kintzel PE, Dorr RT (1995) Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treat Rev 21:33–64
Gurney H (1996) Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. J Clin Oncol 14:2590–2611
Vuyk J (2003) Pharmacodynamics in the elderly. Best Pract Res Clin Anaesthesiol 17:207–218
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41
Kinzel PE, Dorr RT (1995) Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treat Rev 21:33–64
Koren G, Beatty K, Seto A et al (1992) The effects of impaired liver function on the elimination of antineoplastic agents. Ann Pharmacother 26:363–371
Balducci L, Extermann M (1997) Cancer chemotherapy in the older patient: what the medical oncologist needs to know. Cancer 80:1317–1322
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Cova, D., Lorusso, V., Silvestris, N. (2006). The Pharmacokinetics and Pharmacodynamics of Drugs in Elderly Cachectic (Cancer) Patients. In: Mantovani, G., et al. Cachexia and Wasting: A Modern Approach. Springer, Milano. https://doi.org/10.1007/978-88-470-0552-5_37
Download citation
DOI: https://doi.org/10.1007/978-88-470-0552-5_37
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0471-9
Online ISBN: 978-88-470-0552-5
eBook Packages: MedicineMedicine (R0)